Autopsy report · NCT00995722

Efficacy of Prednisone In the Treatment of Ocular Myasthenia

“Slow recruitment rate”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 2 months before it started.
• Ran for about 1 year 10 months before it stopped.
• 11 participants enrolled.
• Results were posted on the registry 2 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Michael Benatar

Sponsor type

University, hospital or other

Conditions

Ocular Myasthenia Gravis

Interventions

Prednisone; Placebo

Participants

11

Sites

10

Countries

Canada, United States

Trials that died the same way

• Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
  “Recruitment Rate too slow” (96% match in meaning)
• Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients
  “Slower than expected recruitment rate” (94% match in meaning)
• Patient Satisfaction and Visual Outcomes After Bilateral PanOptix Implantation in Patients With Previous Multifocal Contact Lens
  “recruitment slow” (94% match in meaning)
• Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis
  “Slow recruitment” (94% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.